Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.790
+0.070 (4.07%)
Jun 26, 2026, 11:58 AM EDT - Market open
Imunon Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.79 | 8.78 | 5.87 | 5.84 | 11.49 | 19.59 |
Short-Term Investments | - | - | - | 9.86 | 21.25 | 29.8 |
Cash & Short-Term Investments | 4.79 | 8.78 | 5.87 | 15.7 | 32.75 | 49.39 |
Cash Growth | 66.94% | 49.52% | -62.58% | -52.07% | -33.70% | 187.75% |
Other Receivables | - | - | - | - | 0.13 | 0.11 |
Total Trade Receivables | - | - | - | - | 0.13 | 0.11 |
Other Current Assets | 1.83 | 1.94 | 2.14 | 2.55 | 3.9 | 2.45 |
Total Current Assets | 6.62 | 10.72 | 8.01 | 18.24 | 36.78 | 51.95 |
Net Property, Plant & Equipment | 1.35 | 1.51 | 1.66 | 2.35 | 0.7 | 1.17 |
Other Intangible Assets | - | - | - | - | - | 13.37 |
Other Long-Term Assets | 0.05 | 0.05 | 0.05 | 1.33 | 6.49 | 7.57 |
Total Assets | 8.02 | 12.29 | 9.72 | 21.92 | 43.98 | 74.05 |
Accounts Payable | 0.96 | 1.39 | 1.3 | 3.52 | 3.59 | 2.55 |
Accrued Expenses | 2.78 | 2.82 | 3.03 | 3.39 | 4.79 | 3.17 |
Current Portion of Long-Term Debt | - | - | - | - | 1.42 | - |
Current Portion of Leases | 0.42 | 0.41 | 0.45 | 0.49 | 0.23 | 0.55 |
Unearned Revenue | - | - | - | - | - | 0.5 |
Total Current Liabilities | 4.17 | 4.62 | 4.79 | 7.39 | 10.04 | 6.77 |
Long-Term Debt | - | - | - | - | 4.61 | 5.85 |
Long-Term Leases | 0.49 | 0.6 | 0.69 | 1.14 | - | 0.23 |
Other Long-Term Liabilities | - | - | - | - | - | 5.4 |
Total Long-Term Liabilities | 0.49 | 0.6 | 0.69 | 1.14 | 4.61 | 11.48 |
Total Liabilities | 4.66 | 5.23 | 5.47 | 8.53 | 14.65 | 18.25 |
Common Stock | 0.04 | 0.03 | 0.01 | 0.09 | 0.07 | 0.06 |
Treasury Stock | -0.09 | -0.09 | -0.09 | -0.09 | -0.09 | -0.09 |
Additional Paid-in Capital | 428.95 | 428.41 | 411.12 | 401.5 | 397.98 | 388.6 |
Accumulated Other Comprehensive Income | - | - | - | 0.06 | 0.03 | -0.01 |
Retained Earnings | -425.55 | -421.3 | -406.8 | -388.18 | -368.67 | -332.77 |
Shareholders' Equity | 3.36 | 7.06 | 4.24 | 13.39 | 29.33 | 55.8 |
Total Liabilities & Equity | 8.02 | 12.29 | 9.72 | 21.92 | 43.98 | 74.05 |
Total Debt | 0.91 | 1.01 | 1.14 | 1.62 | 6.27 | 6.63 |
Net Cash (Debt) | 3.88 | 7.77 | 4.73 | 14.07 | 26.48 | 42.76 |
Net Cash Growth | -50.05% | 64.20% | -66.36% | -46.86% | -38.06% | 289.77% |
Net Cash Per Share | 1.26 | 3.66 | 4.31 | 20.29 | 48.36 | 102.76 |
Book Value | 3.36 | 7.06 | 4.24 | 13.39 | 29.33 | 55.8 |
Book Value Per Share | 1.09 | 3.33 | 3.86 | 19.31 | 53.55 | 134.10 |
Tangible Book Value | 3.36 | 7.06 | 4.24 | 13.39 | 29.33 | 42.43 |
Tangible Book Value Per Share | 1.09 | 3.33 | 3.86 | 19.31 | 53.55 | 101.98 |